Botulinum Neurotoxin for Dermatologic and Cosmetic Disorders

Botulinum Toxin: Therapeutic Clinical Practice and Science

Volumn , Issue , 2009, Pages 324-338

  Glaser, Dee Anna ^a,b  

^a Department of Dermatology ^*  (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952099674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4928-9.00026-3     Document Type: Chapter

References (49)

1. The American Society for Aesthetic Plastic Surgery. Cosmetic Surgery National Data Bank. 2005 Statistics, multispecialty expanded data for 2005. . Accessed September 14, 2007. http://www.surgery.org.
2. de Boulle K Botulinum Neurotoxin Type A in Facial Aesthetics. Expert Opinion On Pharmacotherapy 2007, 1059-1072. Ashley Publications, London.
3. Jost W, Kohl A, Brinkmann S, Comes G Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers. J Neural Transm 2005, 112:905-913.
4. Wenzel R, Jones D, Borrego J Comparing two botulinum toxin type A formulations using manufacturers' product summaries. J Clin Pharm Ther 2007, 32:387-402.
5. Sampaio C, Costa J, Ferreira J Clinical comparability of marketed formulations of botulinum toxin. Mov Disord 2004, 19(suppl 8):S129-S136.
6. Chapman M, Barron R, Tanis D, Gill C, Charles P Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia. Clin Ther 2007, 29:1325-1337.
7. Zimbler M, Kokoska M, Thomas J Anatomy and pathophysiology of facial aging. Facial Plast Surg Clin North Am 2001, 9:179-187.
8. Draelos ZD Concepts in a multiprong approach to photoaging. Skin Therapy Lett 2006, 11:1-3.
9. Coleman K, Carruthers J Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 2006, 19:177-188.
10. Flynn T Update on botulinum toxin. Semin Cutan Med Surg 2006, 25:115-121.
11. Semchyshyn N, Kilmer SL Does laser inactivate botulinum toxin?. Dermatol Surg 2005, 31:399-404.
12. Wise J, Greco T Injectable treatments for the aging face. Facial Plast Surg 2006, 22:140-146.
13. Carruthers A, Carruthers J Upper face treatment. Procedures in Cosmetic Dermatology 2005, 31-44. Elsevier Saunders, Philadelphia. A. Carruthers, J. Carruthers (Eds.).
14. Carruthers J, Carruthers A Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg 2007, 33(suppl 1):S10-S17.
15. Sarifakioglu N, Sarifakioglu E Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-A injections at different locations: a prospective, single-blinded, randomized controlled trial. Aesth Plast Surg 2005, 29:113-115.
16. Alam M, Dover J, Arndt K Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol 2002, 138:510-514.
17. Carruthers A, Carruthers J, Cohen J Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides. Dermatol Surg 2007, 33:S97-104.
18. Flynn T, Carruthers A, Carruthers J Surgical pearl: the use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol 2002, 46:931-933.
19. Carruthers A, Carruthers J Single-center, double-blind, randomized study to evaluate the efficacy of 4% lidocaine cream versus vehicle cream during botulinum toxin type A treatments. Dermatol Surg 2005, 31:1655-1659.
20. Carruthers J, Lowe NJ, Menter M, Gibson J, Nordquist M, Morgaunt J, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002, 46:840-849.
21. Carruthers A, Carruthers J, Said S Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 2005, 31:414-422. discussion 422.
22. Carruthers J, Lowe NJ, Menter M, Gibson J, Eadie N Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 2003, 112:1089-1098. BOTOX Glabellar Lines II Study Group.
23. Carruthers A, Carruthers J Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005, 31:1297-1303.
24. Monheit GD, Carruthers A, Brandt F, Rand R A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 2007, 33:S51-59.
25. Rzany BD, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 2006, 142:320-326.
26. Carruthers A, Carruthers J Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg 2007, 33:S26-S31.
27. Petrus G, Lewis D, Maas CS Anatomic considerations for treatment with botulinum toxin. Facial Plast Surg Clin North Am 2007, 15:1-9.
28. Semchyshyn N, Sengelmann R Botulinum toxin A treatment of perioral rhytides. Dermatol Surg 2003, 29:490-495.
29. Dayan S, Maas C Botulinum toxins for facial wrinkles: beyond glabellar lines. Facial Plast Surg Clin North Am 2008, 15:41-49.
30. Carruthers J, Carruthers A Periorbital area. Using Botulinum Toxins Cosmetically 2003, 39-44. Martin Dunitz Publishing, United Kingdom, . A. Carruthers, J. Carruthers (Eds.).
31. Kane M The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 2003, 112(Suppl 5):66S-72S.
32. Brandt F, Boker A Botulinum toxin for the treatment of neck lines and neck bands. Dermatol Clin 2004, 22:159-166.
33. Matarasso A, Matarasso S, Brandt F, Bellman B Botulinum A exotoxin for the management of platysma bands. Plast Reconstr Surg 1999, 103:645-652. (discussion 653-655).
34. Choe SW, Cho WI, Lee CK, Seo SJ Effects of botulinum toxin type A on contouring of the lower face. Dermatol Surg 2005, 31:502-507. (discussion 507-508).
35. To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001, 54:197-200.
36. Kim NH, Chung J, Park RH, Park JB The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconst Surg 2005, 115:919-930.
37. Carruthers J, Carruthers A Complications of botulinum toxin type A. Facial Plast Surg Clin North Am 2007, 15:51-54.
38. van Laborde S, Dover J, Moore M, Stewart B, Arndt K, Alam M Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: A double-blind, randomized controlled trial. J Am Acad Dermatol 2003, 48:875-877.
39. Sami M, Soparkar C, Patrinely J, Hollier LM, Hollier LH Efficacy of botulinum toxin type A after topical anesthesia. Ophthal Plast Reconstr Surg 2006, 22:448-452.
40. Elibol O, Ozkan B, Hekimhan P, Caglar Y Efficacy of skin cooling and EMLA cream application for pain relief of periocular botulinum toxin injection. Ophthal Plast Reconstr Surg 2007, 23:130-133.
41. Krishtul A, Waldorf H, Blitzer A Complications of cosmetic botulinum toxin therapy. Procedures in Cosmetic Dermatology: Botulinum Toxin 2005, 121-132. Elsevier Saunders, Philadelphia. A. Carruthers, J. Carruthers (Eds.).
42. Flynn T, Clark R Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion. Dermatol Surg 2003, 29:519-522.
43. Trindade de Almeida A, Marques E, De Almeida J, Cunha T, Boraso R Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 2007, 33:S37-S43.
44. Hsu T, Dover J, Arndt K Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 2004, 140:1351-1354.
45. Northington M, Huang C Dry eyes and superficial punctate keratitis: a complication of treatment of glabelar dynamic rhytides with botulinum exotoxin A. Dermatol Surg 2004, 30:1515-1517.
46. Matarasso S Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytids. Dermatol Surg 2002, 28:149-152.
47. Prado A, Fuentes P, Guerra C, Leniz P, Wisnia P Pseudoaneurysm of the frontal branch of the superficial temporal artery: an unusual complication after the injection of botox. Plast Reconstr Surg 2007, 119:2334-2335.
48. Cote T, Mohan A, Polder J, Walton MK, Braun MM Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005, 53:407-415.
49. White L, Tanzi E, Alster T Improving patient retention after botulinum toxin type A treatment. Dermatol Surg 2006, 32:212-215.